• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARTHROSURFACE, INC. ARTHROSURFACE TOEMOTION; ARTHROSURFACE® TOTAL TOE - PROXIMAL PHALANX IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARTHROSURFACE, INC. ARTHROSURFACE TOEMOTION; ARTHROSURFACE® TOTAL TOE - PROXIMAL PHALANX IMPLANT Back to Search Results
Device Problem Loose or Intermittent Connection (1371)
Patient Problems Unspecified Infection (1930); Pain (1994); No Code Available (3191)
Event Date 01/29/2016
Event Type  Injury  
Manufacturer Narrative
Patient was initially implanted with toemotion components on (b)(6) 0215.Since he developed pain and infection, the components were replaced with new ones except the taper post on the meta-tarsal side on (b)(6) 2016.The surgeon suspected that the implant might have loosened.A culture was obtained during the revision surgery.Later, the swab sample analysis revealed staphylococcus lugdunensis (coagulation negative staph).Should any further reportable information is received, supplemental report shall be filed.Following are the details of components explanted from the patient: 1.Part # 9m52-2545-w, lot # 75be1706, mfg dt: 05-2015, exp dt: 04-2022; 2.Part # 9p15-s180-a, lot # 75ae3004, mfg dt: 03-2015, exp dt: 03-2020; 3.Part # 9p15-pb01-a, lot # 75ae3014, mfg dt: 02-2015, exp dt: 02-2020.
 
Event Description
The patient was re-operated since he developed pain, peri-prosthetic infection and osteomyelitis with arthrosurface toemotion implants.It was also reported that the initial implant was loosened as indicated by surgeon during the revision surgery.
 
Manufacturer Narrative
Per the latest follow-up, all total toe components were removed from the patient due to staph infection and bone cement (spacer) with antibiotics was placed.It is not known as to what contributed to the infection.The surgeon plans on fusing the joint with allograft/ autograft bone or retaining the spacer if asymptomatic.The complaint is considered closed.No further follow-up required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARTHROSURFACE TOEMOTION
Type of Device
ARTHROSURFACE® TOTAL TOE - PROXIMAL PHALANX IMPLANT
Manufacturer (Section D)
ARTHROSURFACE, INC.
28 forge parkway
franklin MA 02038
Manufacturer (Section G)
PRIMO MEDICAL GROUP
75 mill st
stoughton MA 02072
Manufacturer Contact
phani puppala
28 forge parkway
franklin, MA 02038
5085203003
MDR Report Key5399918
MDR Text Key37183952
Report Number3004154314-2016-00001
Device Sequence Number1
Product Code LZJ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K132496
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor
Reporter Occupation Medical Equipment Company Technician/Representative
Type of Report Initial,Followup
Report Date 02/19/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 01/21/2016
Initial Date FDA Received01/29/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received03/15/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age52 YR
-
-